Vicarious Surgical Inc. RBOT

RBOT Company Overview

Vicarious Surgical Inc. is a U.S.-based medical technology company focused on developing robotic-assisted surgical systems for minimally invasive surgery. The company operates within the healthcare technology and medical device industries, with a primary emphasis on robotics, visualization, and digital surgical platforms. Its core product initiative is the Vicarious Surgical System, a robotic platform designed to enable surgeons to perform procedures through small incisions using miniaturized robotic instruments and immersive visualization technology. The company’s revenue base has historically been limited as it remains in a pre-commercialization stage focused on research, development, regulatory activities, and system validation rather than broad commercial sales.

The company targets hospitals, surgical centers, and healthcare systems seeking robotic-assisted surgical capabilities across general surgery and related procedural categories. Vicarious Surgical has positioned itself around improving dexterity, visualization, and workflow efficiency through a human-inspired robotic architecture and virtual reality-based interface. The company was founded in 2014 by Adam Sachs and Sammy Khalifa and later became publicly traded through a merger with a special purpose acquisition company in 2021. Since its formation, the company has evolved from an early-stage robotics developer into a clinical-stage surgical robotics company pursuing regulatory clearance and eventual commercialization.